nodes	percent_of_prediction	percent_of_DWPC	metapath
Dexamethasone—CYP11A1—Saquinavir—acquired immunodeficiency syndrome	0.0437	0.0589	CbGbCtD
Dexamethasone—CYP2A6—Nevirapine—acquired immunodeficiency syndrome	0.0188	0.0253	CbGbCtD
Dexamethasone—SLCO1A2—Indinavir—acquired immunodeficiency syndrome	0.0181	0.0244	CbGbCtD
Dexamethasone—SLCO1A2—Nelfinavir—acquired immunodeficiency syndrome	0.0176	0.0237	CbGbCtD
Dexamethasone—SLCO1A2—Saquinavir—acquired immunodeficiency syndrome	0.0159	0.0214	CbGbCtD
Dexamethasone—SLCO1A2—Ritonavir—acquired immunodeficiency syndrome	0.0159	0.0214	CbGbCtD
Dexamethasone—ABCC2—Indinavir—acquired immunodeficiency syndrome	0.015	0.0202	CbGbCtD
Dexamethasone—ABCC2—Saquinavir—acquired immunodeficiency syndrome	0.0132	0.0178	CbGbCtD
Dexamethasone—ABCC2—Ritonavir—acquired immunodeficiency syndrome	0.0132	0.0178	CbGbCtD
Dexamethasone—ABCG2—Nelfinavir—acquired immunodeficiency syndrome	0.0132	0.0178	CbGbCtD
Dexamethasone—CYP2B6—Efavirenz—acquired immunodeficiency syndrome	0.013	0.0175	CbGbCtD
Dexamethasone—CYP2A6—Zidovudine—acquired immunodeficiency syndrome	0.0124	0.0166	CbGbCtD
Dexamethasone—CYP2B6—Lopinavir—acquired immunodeficiency syndrome	0.0123	0.0165	CbGbCtD
Dexamethasone—CYP2B6—Nevirapine—acquired immunodeficiency syndrome	0.0123	0.0165	CbGbCtD
Dexamethasone—ABCG2—Saquinavir—acquired immunodeficiency syndrome	0.0119	0.0161	CbGbCtD
Dexamethasone—ABCG2—Ritonavir—acquired immunodeficiency syndrome	0.0119	0.0161	CbGbCtD
Dexamethasone—CYP3A7-CYP3A51P—Delavirdine—acquired immunodeficiency syndrome	0.0116	0.0157	CbGbCtD
Dexamethasone—CYP3A7—Delavirdine—acquired immunodeficiency syndrome	0.0116	0.0157	CbGbCtD
Dexamethasone—ABCG2—Zidovudine—acquired immunodeficiency syndrome	0.0114	0.0154	CbGbCtD
Dexamethasone—CYP2B6—Amprenavir—acquired immunodeficiency syndrome	0.0111	0.0149	CbGbCtD
Dexamethasone—CYP3A7—Indinavir—acquired immunodeficiency syndrome	0.01	0.0135	CbGbCtD
Dexamethasone—CYP3A7-CYP3A51P—Indinavir—acquired immunodeficiency syndrome	0.01	0.0135	CbGbCtD
Dexamethasone—ABCC2—Lamivudine—acquired immunodeficiency syndrome	0.0098	0.0132	CbGbCtD
Dexamethasone—CYP3A7—Nelfinavir—acquired immunodeficiency syndrome	0.00975	0.0131	CbGbCtD
Dexamethasone—CYP3A7-CYP3A51P—Nelfinavir—acquired immunodeficiency syndrome	0.00975	0.0131	CbGbCtD
Dexamethasone—CYP3A5—Nevirapine—acquired immunodeficiency syndrome	0.00965	0.013	CbGbCtD
Dexamethasone—CYP2B6—Nelfinavir—acquired immunodeficiency syndrome	0.00929	0.0125	CbGbCtD
Dexamethasone—ABCG2—Lamivudine—acquired immunodeficiency syndrome	0.00886	0.0119	CbGbCtD
Dexamethasone—CYP3A7-CYP3A51P—Saquinavir—acquired immunodeficiency syndrome	0.00882	0.0119	CbGbCtD
Dexamethasone—CYP3A7-CYP3A51P—Ritonavir—acquired immunodeficiency syndrome	0.00882	0.0119	CbGbCtD
Dexamethasone—CYP3A7—Saquinavir—acquired immunodeficiency syndrome	0.00882	0.0119	CbGbCtD
Dexamethasone—CYP3A7—Ritonavir—acquired immunodeficiency syndrome	0.00882	0.0119	CbGbCtD
Dexamethasone—CYP3A5—Delavirdine—acquired immunodeficiency syndrome	0.00873	0.0117	CbGbCtD
Dexamethasone—CYP3A5—Amprenavir—acquired immunodeficiency syndrome	0.00873	0.0117	CbGbCtD
Dexamethasone—CYP2E1—Ritonavir—acquired immunodeficiency syndrome	0.00851	0.0115	CbGbCtD
Dexamethasone—CYP2B6—Ritonavir—acquired immunodeficiency syndrome	0.0084	0.0113	CbGbCtD
Dexamethasone—CYP2C8—Delavirdine—acquired immunodeficiency syndrome	0.00839	0.0113	CbGbCtD
Dexamethasone—CYP2C8—Amprenavir—acquired immunodeficiency syndrome	0.00839	0.0113	CbGbCtD
Dexamethasone—CYP2C19—Efavirenz—acquired immunodeficiency syndrome	0.00828	0.0111	CbGbCtD
Dexamethasone—CYP2C19—Lopinavir—acquired immunodeficiency syndrome	0.00779	0.0105	CbGbCtD
Dexamethasone—CYP3A5—Indinavir—acquired immunodeficiency syndrome	0.00754	0.0101	CbGbCtD
Dexamethasone—CYP3A5—Nelfinavir—acquired immunodeficiency syndrome	0.00731	0.00985	CbGbCtD
Dexamethasone—CYP2C19—Amprenavir—acquired immunodeficiency syndrome	0.00704	0.00948	CbGbCtD
Dexamethasone—CYP2C19—Delavirdine—acquired immunodeficiency syndrome	0.00704	0.00948	CbGbCtD
Dexamethasone—CYP2C9—Efavirenz—acquired immunodeficiency syndrome	0.00688	0.00927	CbGbCtD
Dexamethasone—CYP3A5—Saquinavir—acquired immunodeficiency syndrome	0.00662	0.0089	CbGbCtD
Dexamethasone—CYP3A5—Ritonavir—acquired immunodeficiency syndrome	0.00662	0.0089	CbGbCtD
Dexamethasone—CYP2C9—Lopinavir—acquired immunodeficiency syndrome	0.00647	0.00871	CbGbCtD
Dexamethasone—CYP2C9—Nevirapine—acquired immunodeficiency syndrome	0.00647	0.00871	CbGbCtD
Dexamethasone—CYP2C8—Saquinavir—acquired immunodeficiency syndrome	0.00636	0.00856	CbGbCtD
Dexamethasone—CYP2C8—Ritonavir—acquired immunodeficiency syndrome	0.00636	0.00856	CbGbCtD
Dexamethasone—CYP2D6—Efavirenz—acquired immunodeficiency syndrome	0.0063	0.00847	CbGbCtD
Dexamethasone—ABCB1—Lopinavir—acquired immunodeficiency syndrome	0.00628	0.00846	CbGbCtD
Dexamethasone—CYP2C8—Zidovudine—acquired immunodeficiency syndrome	0.0061	0.00821	CbGbCtD
Dexamethasone—CYP2C19—Indinavir—acquired immunodeficiency syndrome	0.00608	0.00818	CbGbCtD
Dexamethasone—CYP2D6—Lopinavir—acquired immunodeficiency syndrome	0.00592	0.00797	CbGbCtD
Dexamethasone—CYP2D6—Nevirapine—acquired immunodeficiency syndrome	0.00592	0.00797	CbGbCtD
Dexamethasone—CYP2C19—Nelfinavir—acquired immunodeficiency syndrome	0.0059	0.00794	CbGbCtD
Dexamethasone—CYP2C9—Amprenavir—acquired immunodeficiency syndrome	0.00585	0.00788	CbGbCtD
Dexamethasone—CYP2C9—Delavirdine—acquired immunodeficiency syndrome	0.00585	0.00788	CbGbCtD
Dexamethasone—ABCB1—Amprenavir—acquired immunodeficiency syndrome	0.00568	0.00765	CbGbCtD
Dexamethasone—CYP2D6—Amprenavir—acquired immunodeficiency syndrome	0.00535	0.00721	CbGbCtD
Dexamethasone—CYP2D6—Delavirdine—acquired immunodeficiency syndrome	0.00535	0.00721	CbGbCtD
Dexamethasone—CYP2C19—Saquinavir—acquired immunodeficiency syndrome	0.00534	0.00718	CbGbCtD
Dexamethasone—CYP2C19—Ritonavir—acquired immunodeficiency syndrome	0.00534	0.00718	CbGbCtD
Dexamethasone—CYP2C19—Zidovudine—acquired immunodeficiency syndrome	0.00512	0.00689	CbGbCtD
Dexamethasone—CYP2C9—Indinavir—acquired immunodeficiency syndrome	0.00505	0.0068	CbGbCtD
Dexamethasone—CYP2C9—Nelfinavir—acquired immunodeficiency syndrome	0.00491	0.0066	CbGbCtD
Dexamethasone—ABCB1—Indinavir—acquired immunodeficiency syndrome	0.0049	0.0066	CbGbCtD
Dexamethasone—ABCB1—Nelfinavir—acquired immunodeficiency syndrome	0.00476	0.00641	CbGbCtD
Dexamethasone—CYP2D6—Indinavir—acquired immunodeficiency syndrome	0.00462	0.00622	CbGbCtD
Dexamethasone—CYP2D6—Nelfinavir—acquired immunodeficiency syndrome	0.00449	0.00604	CbGbCtD
Dexamethasone—CYP2C9—Saquinavir—acquired immunodeficiency syndrome	0.00444	0.00597	CbGbCtD
Dexamethasone—CYP2C9—Ritonavir—acquired immunodeficiency syndrome	0.00444	0.00597	CbGbCtD
Dexamethasone—ABCB1—Saquinavir—acquired immunodeficiency syndrome	0.00431	0.0058	CbGbCtD
Dexamethasone—ABCB1—Ritonavir—acquired immunodeficiency syndrome	0.00431	0.0058	CbGbCtD
Dexamethasone—CYP2C9—Zidovudine—acquired immunodeficiency syndrome	0.00425	0.00573	CbGbCtD
Dexamethasone—ABCB1—Zidovudine—acquired immunodeficiency syndrome	0.00413	0.00556	CbGbCtD
Dexamethasone—CYP2D6—Ritonavir—acquired immunodeficiency syndrome	0.00406	0.00546	CbGbCtD
Dexamethasone—CYP2D6—Saquinavir—acquired immunodeficiency syndrome	0.00406	0.00546	CbGbCtD
Dexamethasone—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.004	0.00539	CbGbCtD
Dexamethasone—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.00376	0.00507	CbGbCtD
Dexamethasone—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.00376	0.00507	CbGbCtD
Dexamethasone—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.0034	0.00458	CbGbCtD
Dexamethasone—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.0034	0.00458	CbGbCtD
Dexamethasone—ABCB1—Lamivudine—acquired immunodeficiency syndrome	0.00319	0.0043	CbGbCtD
Dexamethasone—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.00294	0.00396	CbGbCtD
Dexamethasone—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.00285	0.00384	CbGbCtD
Dexamethasone—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.00258	0.00347	CbGbCtD
Dexamethasone—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.00258	0.00347	CbGbCtD
Dexamethasone—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.00247	0.00333	CbGbCtD
Dexamethasone—CYP19A1—semen—acquired immunodeficiency syndrome	0.00243	0.0383	CbGeAlD
Dexamethasone—ANXA1—nerve—acquired immunodeficiency syndrome	0.00216	0.0341	CbGeAlD
Dexamethasone—PLA2G1B—blood plasma—acquired immunodeficiency syndrome	0.00214	0.0337	CbGeAlD
Dexamethasone—ANXA1—blood plasma—acquired immunodeficiency syndrome	0.00163	0.0258	CbGeAlD
Dexamethasone—NR3C2—blood plasma—acquired immunodeficiency syndrome	0.00106	0.0167	CbGeAlD
Dexamethasone—CYP4A11—digestive system—acquired immunodeficiency syndrome	0.000991	0.0156	CbGeAlD
Dexamethasone—NR0B1—lung—acquired immunodeficiency syndrome	0.000963	0.0152	CbGeAlD
Dexamethasone—CYP4A11—vagina—acquired immunodeficiency syndrome	0.000875	0.0138	CbGeAlD
Dexamethasone—PLA2G1B—digestive system—acquired immunodeficiency syndrome	0.000821	0.013	CbGeAlD
Dexamethasone—ANXA1—skin of body—acquired immunodeficiency syndrome	0.000785	0.0124	CbGeAlD
Dexamethasone—PLA2G1B—blood—acquired immunodeficiency syndrome	0.000782	0.0123	CbGeAlD
Dexamethasone—NR3C1—nerve—acquired immunodeficiency syndrome	0.00075	0.0118	CbGeAlD
Dexamethasone—CYP2C19—blood plasma—acquired immunodeficiency syndrome	0.000726	0.0115	CbGeAlD
Dexamethasone—PLA2G1B—lung—acquired immunodeficiency syndrome	0.000686	0.0108	CbGeAlD
Dexamethasone—NR0B1—brain—acquired immunodeficiency syndrome	0.000681	0.0108	CbGeAlD
Dexamethasone—ABCB11—digestive system—acquired immunodeficiency syndrome	0.000639	0.0101	CbGeAlD
Dexamethasone—ANXA1—lymphoid tissue—acquired immunodeficiency syndrome	0.000636	0.01	CbGeAlD
Dexamethasone—PLA2G1B—nervous system—acquired immunodeficiency syndrome	0.000635	0.01	CbGeAlD
Dexamethasone—CYP2C8—blood plasma—acquired immunodeficiency syndrome	0.000633	0.01	CbGeAlD
Dexamethasone—ANXA1—digestive system—acquired immunodeficiency syndrome	0.000628	0.00991	CbGeAlD
Dexamethasone—PLA2G1B—central nervous system—acquired immunodeficiency syndrome	0.000612	0.00965	CbGeAlD
Dexamethasone—ANXA1—blood—acquired immunodeficiency syndrome	0.000598	0.00944	CbGeAlD
Dexamethasone—NR3C2—retina—acquired immunodeficiency syndrome	0.000579	0.00914	CbGeAlD
Dexamethasone—ANXA1—bone marrow—acquired immunodeficiency syndrome	0.000579	0.00914	CbGeAlD
Dexamethasone—ANXA1—spinal cord—acquired immunodeficiency syndrome	0.000576	0.0091	CbGeAlD
Dexamethasone—CYP3A5—blood plasma—acquired immunodeficiency syndrome	0.000572	0.00902	CbGeAlD
Dexamethasone—CYP2B6—blood plasma—acquired immunodeficiency syndrome	0.000568	0.00897	CbGeAlD
Dexamethasone—NR3C1—blood plasma—acquired immunodeficiency syndrome	0.000567	0.00895	CbGeAlD
Dexamethasone—CYP2C9—blood plasma—acquired immunodeficiency syndrome	0.000563	0.00888	CbGeAlD
Dexamethasone—ANXA1—vagina—acquired immunodeficiency syndrome	0.000555	0.00875	CbGeAlD
Dexamethasone—PTGS2—endothelium—acquired immunodeficiency syndrome	0.000553	0.00872	CbGeAlD
Dexamethasone—CYP2E1—blood plasma—acquired immunodeficiency syndrome	0.000533	0.00841	CbGeAlD
Dexamethasone—ANXA1—lung—acquired immunodeficiency syndrome	0.000525	0.00828	CbGeAlD
Dexamethasone—CYP11A1—blood—acquired immunodeficiency syndrome	0.000499	0.00787	CbGeAlD
Dexamethasone—PTGS2—blood plasma—acquired immunodeficiency syndrome	0.000491	0.00775	CbGeAlD
Dexamethasone—ANXA1—nervous system—acquired immunodeficiency syndrome	0.000486	0.00766	CbGeAlD
Dexamethasone—PLA2G1B—brain—acquired immunodeficiency syndrome	0.000486	0.00766	CbGeAlD
Dexamethasone—ANXA1—central nervous system—acquired immunodeficiency syndrome	0.000468	0.00738	CbGeAlD
Dexamethasone—CYP17A1—nervous system—acquired immunodeficiency syndrome	0.000435	0.00687	CbGeAlD
Dexamethasone—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.000429	0.00677	CbGeAlD
Dexamethasone—CYP2D6—blood plasma—acquired immunodeficiency syndrome	0.000422	0.00666	CbGeAlD
Dexamethasone—CYP17A1—central nervous system—acquired immunodeficiency syndrome	0.000419	0.00661	CbGeAlD
Dexamethasone—NR3C2—digestive system—acquired immunodeficiency syndrome	0.000407	0.00642	CbGeAlD
Dexamethasone—CYP11A1—nervous system—acquired immunodeficiency syndrome	0.000405	0.00639	CbGeAlD
Dexamethasone—CYP1B1—skin of body—acquired immunodeficiency syndrome	0.000398	0.00627	CbGeAlD
Dexamethasone—CYP11A1—central nervous system—acquired immunodeficiency syndrome	0.00039	0.00615	CbGeAlD
Dexamethasone—NR3C2—blood—acquired immunodeficiency syndrome	0.000387	0.00611	CbGeAlD
Dexamethasone—CYP2A6—vagina—acquired immunodeficiency syndrome	0.000383	0.00605	CbGeAlD
Dexamethasone—PGR—lymphoid tissue—acquired immunodeficiency syndrome	0.000383	0.00604	CbGeAlD
Dexamethasone—NR3C2—spinal cord—acquired immunodeficiency syndrome	0.000373	0.00589	CbGeAlD
Dexamethasone—ANXA1—brain—acquired immunodeficiency syndrome	0.000371	0.00586	CbGeAlD
Dexamethasone—CYP2A6—lung—acquired immunodeficiency syndrome	0.000362	0.00572	CbGeAlD
Dexamethasone—PGR—blood—acquired immunodeficiency syndrome	0.00036	0.00568	CbGeAlD
Dexamethasone—NR3C2—vagina—acquired immunodeficiency syndrome	0.000359	0.00567	CbGeAlD
Dexamethasone—ANXA1—lymph node—acquired immunodeficiency syndrome	0.000359	0.00566	CbGeAlD
Dexamethasone—SLCO1A2—digestive system—acquired immunodeficiency syndrome	0.000349	0.0055	CbGeAlD
Dexamethasone—NR3C2—lung—acquired immunodeficiency syndrome	0.00034	0.00536	CbGeAlD
Dexamethasone—PGR—vagina—acquired immunodeficiency syndrome	0.000334	0.00527	CbGeAlD
Dexamethasone—CYP17A1—brain—acquired immunodeficiency syndrome	0.000333	0.00525	CbGeAlD
Dexamethasone—ABCC2—digestive system—acquired immunodeficiency syndrome	0.000325	0.00512	CbGeAlD
Dexamethasone—CYP19A1—blood—acquired immunodeficiency syndrome	0.000324	0.00511	CbGeAlD
Dexamethasone—CYP1B1—lymphoid tissue—acquired immunodeficiency syndrome	0.000322	0.00508	CbGeAlD
Dexamethasone—CYP17A1—lymph node—acquired immunodeficiency syndrome	0.000322	0.00507	CbGeAlD
Dexamethasone—SLCO1A2—spinal cord—acquired immunodeficiency syndrome	0.00032	0.00505	CbGeAlD
Dexamethasone—CYP1B1—digestive system—acquired immunodeficiency syndrome	0.000318	0.00502	CbGeAlD
Dexamethasone—PGR—lung—acquired immunodeficiency syndrome	0.000316	0.00498	CbGeAlD
Dexamethasone—NR3C2—nervous system—acquired immunodeficiency syndrome	0.000315	0.00496	CbGeAlD
Dexamethasone—CYP11A1—brain—acquired immunodeficiency syndrome	0.00031	0.00488	CbGeAlD
Dexamethasone—ABCC2—blood—acquired immunodeficiency syndrome	0.000309	0.00488	CbGeAlD
Dexamethasone—ABCB1—blood plasma—acquired immunodeficiency syndrome	0.000304	0.00479	CbGeAlD
Dexamethasone—CYP1B1—blood—acquired immunodeficiency syndrome	0.000303	0.00478	CbGeAlD
Dexamethasone—NR3C2—central nervous system—acquired immunodeficiency syndrome	0.000303	0.00478	CbGeAlD
Dexamethasone—CYP11A1—lymph node—acquired immunodeficiency syndrome	0.000299	0.00472	CbGeAlD
Dexamethasone—PGR—nervous system—acquired immunodeficiency syndrome	0.000292	0.00461	CbGeAlD
Dexamethasone—SLCO1A2—lung—acquired immunodeficiency syndrome	0.000291	0.00459	CbGeAlD
Dexamethasone—PGR—central nervous system—acquired immunodeficiency syndrome	0.000282	0.00444	CbGeAlD
Dexamethasone—CYP1A1—skin of body—acquired immunodeficiency syndrome	0.000281	0.00444	CbGeAlD
Dexamethasone—CYP2C19—digestive system—acquired immunodeficiency syndrome	0.000279	0.0044	CbGeAlD
Dexamethasone—CYP2B6—skin of body—acquired immunodeficiency syndrome	0.000273	0.00431	CbGeAlD
Dexamethasone—NR3C1—skin of body—acquired immunodeficiency syndrome	0.000273	0.0043	CbGeAlD
Dexamethasone—SLCO1A2—nervous system—acquired immunodeficiency syndrome	0.00027	0.00425	CbGeAlD
Dexamethasone—CYP2C19—blood—acquired immunodeficiency syndrome	0.000266	0.0042	CbGeAlD
Dexamethasone—CYP1B1—lung—acquired immunodeficiency syndrome	0.000266	0.00419	CbGeAlD
Dexamethasone—CYP19A1—nervous system—acquired immunodeficiency syndrome	0.000263	0.00415	CbGeAlD
Dexamethasone—SLCO1A2—central nervous system—acquired immunodeficiency syndrome	0.00026	0.0041	CbGeAlD
Dexamethasone—CYP2A6—brain—acquired immunodeficiency syndrome	0.000257	0.00405	CbGeAlD
Dexamethasone—CYP19A1—central nervous system—acquired immunodeficiency syndrome	0.000253	0.004	CbGeAlD
Dexamethasone—CYP2C19—vagina—acquired immunodeficiency syndrome	0.000246	0.00389	CbGeAlD
Dexamethasone—CYP1B1—nervous system—acquired immunodeficiency syndrome	0.000246	0.00388	CbGeAlD
Dexamethasone—NR3C2—brain—acquired immunodeficiency syndrome	0.00024	0.00379	CbGeAlD
Dexamethasone—CYP1B1—central nervous system—acquired immunodeficiency syndrome	0.000237	0.00374	CbGeAlD
Dexamethasone—PTGS2—skin of body—acquired immunodeficiency syndrome	0.000236	0.00372	CbGeAlD
Dexamethasone—NR3C2—lymph node—acquired immunodeficiency syndrome	0.000232	0.00367	CbGeAlD
Dexamethasone—CYP2C8—blood—acquired immunodeficiency syndrome	0.000232	0.00366	CbGeAlD
Dexamethasone—ABCG2—blood—acquired immunodeficiency syndrome	0.000226	0.00356	CbGeAlD
Dexamethasone—CYP1A1—digestive system—acquired immunodeficiency syndrome	0.000225	0.00355	CbGeAlD
Dexamethasone—PGR—brain—acquired immunodeficiency syndrome	0.000223	0.00353	CbGeAlD
Dexamethasone—CYP2B6—lymphoid tissue—acquired immunodeficiency syndrome	0.000221	0.00349	CbGeAlD
Dexamethasone—NR3C1—lymphoid tissue—acquired immunodeficiency syndrome	0.000221	0.00348	CbGeAlD
Dexamethasone—CYP3A5—digestive system—acquired immunodeficiency syndrome	0.00022	0.00347	CbGeAlD
Dexamethasone—CYP2B6—digestive system—acquired immunodeficiency syndrome	0.000218	0.00345	CbGeAlD
Dexamethasone—ABCG2—bone marrow—acquired immunodeficiency syndrome	0.000218	0.00344	CbGeAlD
Dexamethasone—NR3C1—digestive system—acquired immunodeficiency syndrome	0.000218	0.00344	CbGeAlD
Dexamethasone—ABCG2—spinal cord—acquired immunodeficiency syndrome	0.000217	0.00343	CbGeAlD
Dexamethasone—CYP2C9—digestive system—acquired immunodeficiency syndrome	0.000216	0.00341	CbGeAlD
Dexamethasone—PGR—lymph node—acquired immunodeficiency syndrome	0.000216	0.00341	CbGeAlD
Dexamethasone—CYP2C8—vagina—acquired immunodeficiency syndrome	0.000215	0.00339	CbGeAlD
Dexamethasone—CYP1A1—blood—acquired immunodeficiency syndrome	0.000214	0.00338	CbGeAlD
Dexamethasone—CYP3A5—blood—acquired immunodeficiency syndrome	0.000209	0.0033	CbGeAlD
Dexamethasone—ABCG2—vagina—acquired immunodeficiency syndrome	0.000209	0.0033	CbGeAlD
Dexamethasone—CYP2B6—blood—acquired immunodeficiency syndrome	0.000208	0.00328	CbGeAlD
Dexamethasone—NR3C1—blood—acquired immunodeficiency syndrome	0.000208	0.00328	CbGeAlD
Dexamethasone—CYP2E1—lymphoid tissue—acquired immunodeficiency syndrome	0.000208	0.00328	CbGeAlD
Dexamethasone—CYP2C9—blood—acquired immunodeficiency syndrome	0.000206	0.00325	CbGeAlD
Dexamethasone—SLCO1A2—brain—acquired immunodeficiency syndrome	0.000206	0.00325	CbGeAlD
Dexamethasone—CYP2E1—digestive system—acquired immunodeficiency syndrome	0.000205	0.00324	CbGeAlD
Dexamethasone—CYP19A1—brain—acquired immunodeficiency syndrome	0.000201	0.00317	CbGeAlD
Dexamethasone—NR3C1—bone marrow—acquired immunodeficiency syndrome	0.000201	0.00317	CbGeAlD
Dexamethasone—NR3C1—spinal cord—acquired immunodeficiency syndrome	0.0002	0.00316	CbGeAlD
Dexamethasone—CYP1A1—vagina—acquired immunodeficiency syndrome	0.000199	0.00313	CbGeAlD
Dexamethasone—ABCG2—lung—acquired immunodeficiency syndrome	0.000198	0.00312	CbGeAlD
Dexamethasone—CYP2E1—blood—acquired immunodeficiency syndrome	0.000195	0.00308	CbGeAlD
Dexamethasone—CYP19A1—lymph node—acquired immunodeficiency syndrome	0.000194	0.00307	CbGeAlD
Dexamethasone—CYP3A5—vagina—acquired immunodeficiency syndrome	0.000194	0.00306	CbGeAlD
Dexamethasone—CYP2B6—vagina—acquired immunodeficiency syndrome	0.000193	0.00304	CbGeAlD
Dexamethasone—NR3C1—vagina—acquired immunodeficiency syndrome	0.000193	0.00304	CbGeAlD
Dexamethasone—PTGS2—lymphoid tissue—acquired immunodeficiency syndrome	0.000191	0.00302	CbGeAlD
Dexamethasone—PTGS2—digestive system—acquired immunodeficiency syndrome	0.000189	0.00298	CbGeAlD
Dexamethasone—CYP2E1—spinal cord—acquired immunodeficiency syndrome	0.000188	0.00297	CbGeAlD
Dexamethasone—CYP1B1—brain—acquired immunodeficiency syndrome	0.000188	0.00297	CbGeAlD
Dexamethasone—CYP1A1—lung—acquired immunodeficiency syndrome	0.000188	0.00296	CbGeAlD
Dexamethasone—ABCC2—lymph node—acquired immunodeficiency syndrome	0.000186	0.00293	CbGeAlD
Dexamethasone—CYP3A5—lung—acquired immunodeficiency syndrome	0.000184	0.0029	CbGeAlD
Dexamethasone—CYP2B6—lung—acquired immunodeficiency syndrome	0.000182	0.00288	CbGeAlD
Dexamethasone—NR3C1—lung—acquired immunodeficiency syndrome	0.000182	0.00287	CbGeAlD
Dexamethasone—CYP1B1—lymph node—acquired immunodeficiency syndrome	0.000182	0.00287	CbGeAlD
Dexamethasone—PTGS2—blood—acquired immunodeficiency syndrome	0.00018	0.00284	CbGeAlD
Dexamethasone—PTGS2—bone marrow—acquired immunodeficiency syndrome	0.000174	0.00275	CbGeAlD
Dexamethasone—CYP1A1—nervous system—acquired immunodeficiency syndrome	0.000174	0.00274	CbGeAlD
Dexamethasone—PTGS2—spinal cord—acquired immunodeficiency syndrome	0.000173	0.00273	CbGeAlD
Dexamethasone—CYP2E1—lung—acquired immunodeficiency syndrome	0.000171	0.0027	CbGeAlD
Dexamethasone—CYP2B6—nervous system—acquired immunodeficiency syndrome	0.000169	0.00267	CbGeAlD
Dexamethasone—NR3C1—nervous system—acquired immunodeficiency syndrome	0.000169	0.00266	CbGeAlD
Dexamethasone—CYP1A1—central nervous system—acquired immunodeficiency syndrome	0.000167	0.00264	CbGeAlD
Dexamethasone—PTGS2—vagina—acquired immunodeficiency syndrome	0.000167	0.00263	CbGeAlD
Dexamethasone—ABCB1—retina—acquired immunodeficiency syndrome	0.000166	0.00262	CbGeAlD
Dexamethasone—CYP3A4—digestive system—acquired immunodeficiency syndrome	0.000165	0.0026	CbGeAlD
Dexamethasone—CYP2B6—central nervous system—acquired immunodeficiency syndrome	0.000163	0.00257	CbGeAlD
Dexamethasone—NR3C1—central nervous system—acquired immunodeficiency syndrome	0.000162	0.00256	CbGeAlD
Dexamethasone—CYP2D6—digestive system—acquired immunodeficiency syndrome	0.000162	0.00256	CbGeAlD
Dexamethasone—CYP2E1—nervous system—acquired immunodeficiency syndrome	0.000159	0.0025	CbGeAlD
Dexamethasone—PTGS2—lung—acquired immunodeficiency syndrome	0.000158	0.00249	CbGeAlD
Dexamethasone—CYP3A4—blood—acquired immunodeficiency syndrome	0.000157	0.00248	CbGeAlD
Dexamethasone—CYP2D6—blood—acquired immunodeficiency syndrome	0.000155	0.00244	CbGeAlD
Dexamethasone—CYP2E1—central nervous system—acquired immunodeficiency syndrome	0.000153	0.00241	CbGeAlD
Dexamethasone—PTGS2—nervous system—acquired immunodeficiency syndrome	0.000146	0.0023	CbGeAlD
Dexamethasone—CYP2C8—brain—acquired immunodeficiency syndrome	0.000144	0.00227	CbGeAlD
Dexamethasone—PTGS2—central nervous system—acquired immunodeficiency syndrome	0.000141	0.00222	CbGeAlD
Dexamethasone—ABCG2—brain—acquired immunodeficiency syndrome	0.00014	0.00221	CbGeAlD
Dexamethasone—ABCG2—lymph node—acquired immunodeficiency syndrome	0.000135	0.00213	CbGeAlD
Dexamethasone—CYP1A1—brain—acquired immunodeficiency syndrome	0.000133	0.0021	CbGeAlD
Dexamethasone—CYP2B6—brain—acquired immunodeficiency syndrome	0.000129	0.00204	CbGeAlD
Dexamethasone—NR3C1—brain—acquired immunodeficiency syndrome	0.000129	0.00203	CbGeAlD
Dexamethasone—CYP1A1—lymph node—acquired immunodeficiency syndrome	0.000128	0.00203	CbGeAlD
Dexamethasone—CYP3A4—nervous system—acquired immunodeficiency syndrome	0.000128	0.00201	CbGeAlD
Dexamethasone—CYP2D6—nervous system—acquired immunodeficiency syndrome	0.000126	0.00198	CbGeAlD
Dexamethasone—NR3C1—lymph node—acquired immunodeficiency syndrome	0.000125	0.00197	CbGeAlD
Dexamethasone—CYP3A4—central nervous system—acquired immunodeficiency syndrome	0.000123	0.00194	CbGeAlD
Dexamethasone—CYP2E1—brain—acquired immunodeficiency syndrome	0.000121	0.00191	CbGeAlD
Dexamethasone—CYP2D6—central nervous system—acquired immunodeficiency syndrome	0.000121	0.00191	CbGeAlD
Dexamethasone—Vertigo—Ritonavir—acquired immunodeficiency syndrome	0.000121	0.000721	CcSEcCtD
Dexamethasone—Pain—Zidovudine—acquired immunodeficiency syndrome	0.000121	0.00072	CcSEcCtD
Dexamethasone—Asthenia—Nevirapine—acquired immunodeficiency syndrome	0.000121	0.00072	CcSEcCtD
Dexamethasone—Syncope—Ritonavir—acquired immunodeficiency syndrome	0.000121	0.00072	CcSEcCtD
Dexamethasone—Ill-defined disorder—Saquinavir—acquired immunodeficiency syndrome	0.00012	0.000717	CcSEcCtD
Dexamethasone—Hyperhidrosis—Efavirenz—acquired immunodeficiency syndrome	0.00012	0.000716	CcSEcCtD
Dexamethasone—Musculoskeletal discomfort—Indinavir—acquired immunodeficiency syndrome	0.00012	0.000714	CcSEcCtD
Dexamethasone—ANXA1—G alpha (i) signalling events—CCL5—acquired immunodeficiency syndrome	0.000119	0.00456	CbGpPWpGaD
Dexamethasone—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.000119	0.00071	CcSEcCtD
Dexamethasone—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.000119	0.00071	CcSEcCtD
Dexamethasone—Insomnia—Indinavir—acquired immunodeficiency syndrome	0.000119	0.000709	CcSEcCtD
Dexamethasone—Oedema—Delavirdine—acquired immunodeficiency syndrome	0.000119	0.000708	CcSEcCtD
Dexamethasone—Anorexia—Efavirenz—acquired immunodeficiency syndrome	0.000118	0.000706	CcSEcCtD
Dexamethasone—ABCB1—lymphoid tissue—acquired immunodeficiency syndrome	0.000118	0.00187	CbGeAlD
Dexamethasone—Loss of consciousness—Ritonavir—acquired immunodeficiency syndrome	0.000118	0.000705	CcSEcCtD
Dexamethasone—Rash—Didanosine—acquired immunodeficiency syndrome	0.000118	0.000704	CcSEcCtD
Dexamethasone—Infection—Delavirdine—acquired immunodeficiency syndrome	0.000118	0.000704	CcSEcCtD
Dexamethasone—Paraesthesia—Indinavir—acquired immunodeficiency syndrome	0.000118	0.000703	CcSEcCtD
Dexamethasone—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.000118	0.000703	CcSEcCtD
Dexamethasone—Headache—Didanosine—acquired immunodeficiency syndrome	0.000117	0.000699	CcSEcCtD
Dexamethasone—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.000117	0.000698	CcSEcCtD
Dexamethasone—Shock—Delavirdine—acquired immunodeficiency syndrome	0.000117	0.000697	CcSEcCtD
Dexamethasone—ABCB1—digestive system—acquired immunodeficiency syndrome	0.000117	0.00184	CbGeAlD
Dexamethasone—Malaise—Saquinavir—acquired immunodeficiency syndrome	0.000117	0.000697	CcSEcCtD
Dexamethasone—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.000117	0.000695	CcSEcCtD
Dexamethasone—Convulsion—Ritonavir—acquired immunodeficiency syndrome	0.000117	0.000695	CcSEcCtD
Dexamethasone—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	0.000116	0.000694	CcSEcCtD
Dexamethasone—Vertigo—Saquinavir—acquired immunodeficiency syndrome	0.000116	0.000694	CcSEcCtD
Dexamethasone—Thrombocytopenia—Delavirdine—acquired immunodeficiency syndrome	0.000116	0.000693	CcSEcCtD
Dexamethasone—Hypertension—Ritonavir—acquired immunodeficiency syndrome	0.000116	0.000693	CcSEcCtD
Dexamethasone—Syncope—Saquinavir—acquired immunodeficiency syndrome	0.000116	0.000693	CcSEcCtD
Dexamethasone—Tachycardia—Delavirdine—acquired immunodeficiency syndrome	0.000116	0.000691	CcSEcCtD
Dexamethasone—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	0.000116	0.00069	CcSEcCtD
Dexamethasone—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	0.000115	0.000689	CcSEcCtD
Dexamethasone—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.000115	0.000688	CcSEcCtD
Dexamethasone—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.000115	0.000687	CcSEcCtD
Dexamethasone—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.000115	0.000686	CcSEcCtD
Dexamethasone—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.000115	0.000685	CcSEcCtD
Dexamethasone—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	0.000115	0.000685	CcSEcCtD
Dexamethasone—Ill-defined disorder—Lamivudine—acquired immunodeficiency syndrome	0.000115	0.000684	CcSEcCtD
Dexamethasone—Myalgia—Ritonavir—acquired immunodeficiency syndrome	0.000115	0.000683	CcSEcCtD
Dexamethasone—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	0.000114	0.000681	CcSEcCtD
Dexamethasone—Anxiety—Ritonavir—acquired immunodeficiency syndrome	0.000114	0.000681	CcSEcCtD
Dexamethasone—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	0.000114	0.000679	CcSEcCtD
Dexamethasone—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.000113	0.000676	CcSEcCtD
Dexamethasone—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.000113	0.000676	CcSEcCtD
Dexamethasone—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.000113	0.000675	CcSEcCtD
Dexamethasone—Anorexia—Delavirdine—acquired immunodeficiency syndrome	0.000113	0.000675	CcSEcCtD
Dexamethasone—Discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000113	0.000675	CcSEcCtD
Dexamethasone—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.000113	0.000674	CcSEcCtD
Dexamethasone—Angioedema—Lamivudine—acquired immunodeficiency syndrome	0.000113	0.000673	CcSEcCtD
Dexamethasone—Pain—Indinavir—acquired immunodeficiency syndrome	0.000112	0.00067	CcSEcCtD
Dexamethasone—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.000112	0.000669	CcSEcCtD
Dexamethasone—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.000112	0.000669	CcSEcCtD
Dexamethasone—Convulsion—Saquinavir—acquired immunodeficiency syndrome	0.000112	0.000669	CcSEcCtD
Dexamethasone—Hypertension—Saquinavir—acquired immunodeficiency syndrome	0.000112	0.000667	CcSEcCtD
Dexamethasone—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.000112	0.000666	CcSEcCtD
Dexamethasone—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.000112	0.000666	CcSEcCtD
Dexamethasone—PTGS2—brain—acquired immunodeficiency syndrome	0.000112	0.00176	CbGeAlD
Dexamethasone—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000111	0.000665	CcSEcCtD
Dexamethasone—ANXA1—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.000111	0.00427	CbGpPWpGaD
Dexamethasone—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.000111	0.000665	CcSEcCtD
Dexamethasone—Malaise—Lamivudine—acquired immunodeficiency syndrome	0.000111	0.000664	CcSEcCtD
Dexamethasone—ABCB1—blood—acquired immunodeficiency syndrome	0.000111	0.00176	CbGeAlD
Dexamethasone—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000111	0.000663	CcSEcCtD
Dexamethasone—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000111	0.000663	CcSEcCtD
Dexamethasone—Vertigo—Lamivudine—acquired immunodeficiency syndrome	0.000111	0.000662	CcSEcCtD
Dexamethasone—Hypotension—Delavirdine—acquired immunodeficiency syndrome	0.000111	0.000662	CcSEcCtD
Dexamethasone—Syncope—Lamivudine—acquired immunodeficiency syndrome	0.000111	0.000661	CcSEcCtD
Dexamethasone—Myalgia—Saquinavir—acquired immunodeficiency syndrome	0.00011	0.000658	CcSEcCtD
Dexamethasone—Anxiety—Saquinavir—acquired immunodeficiency syndrome	0.00011	0.000655	CcSEcCtD
Dexamethasone—Oedema—Ritonavir—acquired immunodeficiency syndrome	0.00011	0.000655	CcSEcCtD
Dexamethasone—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.00011	0.000653	CcSEcCtD
Dexamethasone—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.000109	0.000652	CcSEcCtD
Dexamethasone—Discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000109	0.00065	CcSEcCtD
Dexamethasone—CYP17A1—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	0.000109	0.00416	CbGpPWpGaD
Dexamethasone—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	0.000109	0.000648	CcSEcCtD
Dexamethasone—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.000108	0.000646	CcSEcCtD
Dexamethasone—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000108	0.000645	CcSEcCtD
Dexamethasone—Shock—Ritonavir—acquired immunodeficiency syndrome	0.000108	0.000644	CcSEcCtD
Dexamethasone—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	0.000108	0.000643	CcSEcCtD
Dexamethasone—PTGS2—lymph node—acquired immunodeficiency syndrome	0.000108	0.0017	CbGeAlD
Dexamethasone—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000108	0.000643	CcSEcCtD
Dexamethasone—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	0.000108	0.000642	CcSEcCtD
Dexamethasone—ABCB1—bone marrow—acquired immunodeficiency syndrome	0.000108	0.0017	CbGeAlD
Dexamethasone—ANXA1—Spinal Cord Injury—IL2—acquired immunodeficiency syndrome	0.000108	0.00412	CbGpPWpGaD
Dexamethasone—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	0.000107	0.000641	CcSEcCtD
Dexamethasone—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000107	0.000641	CcSEcCtD
Dexamethasone—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.000107	0.000641	CcSEcCtD
Dexamethasone—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.000107	0.000641	CcSEcCtD
Dexamethasone—ANXA1—G alpha (i) signalling events—CCR5—acquired immunodeficiency syndrome	0.000107	0.00411	CbGpPWpGaD
Dexamethasone—ABCB1—spinal cord—acquired immunodeficiency syndrome	0.000107	0.00169	CbGeAlD
Dexamethasone—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	0.000107	0.000639	CcSEcCtD
Dexamethasone—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.000107	0.000639	CcSEcCtD
Dexamethasone—Convulsion—Lamivudine—acquired immunodeficiency syndrome	0.000107	0.000638	CcSEcCtD
Dexamethasone—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000107	0.000638	CcSEcCtD
Dexamethasone—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.000107	0.000638	CcSEcCtD
Dexamethasone—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	0.000107	0.000636	CcSEcCtD
Dexamethasone—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.000106	0.000633	CcSEcCtD
Dexamethasone—Pain—Efavirenz—acquired immunodeficiency syndrome	0.000106	0.000633	CcSEcCtD
Dexamethasone—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000106	0.000633	CcSEcCtD
Dexamethasone—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000106	0.000632	CcSEcCtD
Dexamethasone—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000106	0.000631	CcSEcCtD
Dexamethasone—Oedema—Saquinavir—acquired immunodeficiency syndrome	0.000106	0.00063	CcSEcCtD
Dexamethasone—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000105	0.000629	CcSEcCtD
Dexamethasone—Myalgia—Lamivudine—acquired immunodeficiency syndrome	0.000105	0.000627	CcSEcCtD
Dexamethasone—Infection—Saquinavir—acquired immunodeficiency syndrome	0.000105	0.000626	CcSEcCtD
Dexamethasone—Anxiety—Lamivudine—acquired immunodeficiency syndrome	0.000105	0.000625	CcSEcCtD
Dexamethasone—Anorexia—Ritonavir—acquired immunodeficiency syndrome	0.000105	0.000624	CcSEcCtD
Dexamethasone—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.000104	0.000623	CcSEcCtD
Dexamethasone—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.000104	0.000622	CcSEcCtD
Dexamethasone—Shock—Saquinavir—acquired immunodeficiency syndrome	0.000104	0.00062	CcSEcCtD
Dexamethasone—Discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000104	0.00062	CcSEcCtD
Dexamethasone—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.000104	0.000619	CcSEcCtD
Dexamethasone—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.000104	0.000619	CcSEcCtD
Dexamethasone—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	0.000104	0.000618	CcSEcCtD
Dexamethasone—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000104	0.000618	CcSEcCtD
Dexamethasone—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	0.000103	0.000617	CcSEcCtD
Dexamethasone—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000103	0.000616	CcSEcCtD
Dexamethasone—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	0.000103	0.000616	CcSEcCtD
Dexamethasone—ABCB1—vagina—acquired immunodeficiency syndrome	0.000103	0.00163	CbGeAlD
Dexamethasone—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000103	0.000613	CcSEcCtD
Dexamethasone—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000103	0.000612	CcSEcCtD
Dexamethasone—Hypotension—Ritonavir—acquired immunodeficiency syndrome	0.000103	0.000612	CcSEcCtD
Dexamethasone—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.000102	0.000611	CcSEcCtD
Dexamethasone—Rash—Stavudine—acquired immunodeficiency syndrome	0.000102	0.000611	CcSEcCtD
Dexamethasone—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.000102	0.000611	CcSEcCtD
Dexamethasone—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000102	0.000611	CcSEcCtD
Dexamethasone—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.000102	0.00061	CcSEcCtD
Dexamethasone—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	0.000102	0.000609	CcSEcCtD
Dexamethasone—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000102	0.000609	CcSEcCtD
Dexamethasone—Headache—Stavudine—acquired immunodeficiency syndrome	0.000102	0.000607	CcSEcCtD
Dexamethasone—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000102	0.000607	CcSEcCtD
Dexamethasone—Pain—Delavirdine—acquired immunodeficiency syndrome	0.000102	0.000606	CcSEcCtD
Dexamethasone—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.000101	0.000605	CcSEcCtD
Dexamethasone—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000101	0.000604	CcSEcCtD
Dexamethasone—Rash—Abacavir—acquired immunodeficiency syndrome	0.000101	0.000602	CcSEcCtD
Dexamethasone—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000101	0.000601	CcSEcCtD
Dexamethasone—ANXA1—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.000101	0.00386	CbGpPWpGaD
Dexamethasone—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	0.000101	0.000601	CcSEcCtD
Dexamethasone—Oedema—Lamivudine—acquired immunodeficiency syndrome	0.000101	0.000601	CcSEcCtD
Dexamethasone—Anorexia—Saquinavir—acquired immunodeficiency syndrome	0.000101	0.000601	CcSEcCtD
Dexamethasone—Headache—Abacavir—acquired immunodeficiency syndrome	0.0001	0.000598	CcSEcCtD
Dexamethasone—Infection—Lamivudine—acquired immunodeficiency syndrome	0.0001	0.000597	CcSEcCtD
Dexamethasone—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	0.0001	0.000597	CcSEcCtD
Dexamethasone—Nausea—Nevirapine—acquired immunodeficiency syndrome	9.99e-05	0.000596	CcSEcCtD
Dexamethasone—Pruritus—Zidovudine—acquired immunodeficiency syndrome	9.99e-05	0.000596	CcSEcCtD
Dexamethasone—CYP11A1—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	9.94e-05	0.00381	CbGpPWpGaD
Dexamethasone—Insomnia—Ritonavir—acquired immunodeficiency syndrome	9.93e-05	0.000592	CcSEcCtD
Dexamethasone—Shock—Lamivudine—acquired immunodeficiency syndrome	9.92e-05	0.000592	CcSEcCtD
Dexamethasone—NR0B1—Gene Expression—CCNT1—acquired immunodeficiency syndrome	9.89e-05	0.00379	CbGpPWpGaD
Dexamethasone—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	9.89e-05	0.00059	CcSEcCtD
Dexamethasone—NR3C1—AP-1 transcription factor network—IL10—acquired immunodeficiency syndrome	9.88e-05	0.00378	CbGpPWpGaD
Dexamethasone—Hypotension—Saquinavir—acquired immunodeficiency syndrome	9.87e-05	0.000589	CcSEcCtD
Dexamethasone—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	9.87e-05	0.000589	CcSEcCtD
Dexamethasone—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	9.86e-05	0.000588	CcSEcCtD
Dexamethasone—Urticaria—Efavirenz—acquired immunodeficiency syndrome	9.86e-05	0.000588	CcSEcCtD
Dexamethasone—CYP4A11—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	9.84e-05	0.00377	CbGpPWpGaD
Dexamethasone—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	9.81e-05	0.000585	CcSEcCtD
Dexamethasone—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	9.81e-05	0.000585	CcSEcCtD
Dexamethasone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—acquired immunodeficiency syndrome	9.8e-05	0.00375	CbGpPWpGaD
Dexamethasone—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	9.78e-05	0.000584	CcSEcCtD
Dexamethasone—NR3C1—AP-1 transcription factor network—CSF2—acquired immunodeficiency syndrome	9.77e-05	0.00374	CbGpPWpGaD
Dexamethasone—ABCB1—lung—acquired immunodeficiency syndrome	9.75e-05	0.00154	CbGeAlD
Dexamethasone—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	9.74e-05	0.000581	CcSEcCtD
Dexamethasone—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	9.71e-05	0.000579	CcSEcCtD
Dexamethasone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CSF2—acquired immunodeficiency syndrome	9.69e-05	0.00371	CbGpPWpGaD
Dexamethasone—Nausea—Nelfinavir—acquired immunodeficiency syndrome	9.68e-05	0.000577	CcSEcCtD
Dexamethasone—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	9.66e-05	0.000577	CcSEcCtD
Dexamethasone—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	9.66e-05	0.000576	CcSEcCtD
Dexamethasone—Nausea—Stavudine—acquired immunodeficiency syndrome	9.65e-05	0.000576	CcSEcCtD
Dexamethasone—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	9.63e-05	0.000574	CcSEcCtD
Dexamethasone—NR3C1—AP-1 transcription factor network—IL4—acquired immunodeficiency syndrome	9.61e-05	0.00368	CbGpPWpGaD
Dexamethasone—Anorexia—Lamivudine—acquired immunodeficiency syndrome	9.61e-05	0.000573	CcSEcCtD
Dexamethasone—CYP2D6—brain—acquired immunodeficiency syndrome	9.6e-05	0.00151	CbGeAlD
Dexamethasone—Insomnia—Saquinavir—acquired immunodeficiency syndrome	9.56e-05	0.00057	CcSEcCtD
Dexamethasone—PGR—Generic Transcription Pathway—CCNT1—acquired immunodeficiency syndrome	9.55e-05	0.00366	CbGpPWpGaD
Dexamethasone—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	9.54e-05	0.000569	CcSEcCtD
Dexamethasone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL4—acquired immunodeficiency syndrome	9.53e-05	0.00365	CbGpPWpGaD
Dexamethasone—Nausea—Abacavir—acquired immunodeficiency syndrome	9.51e-05	0.000567	CcSEcCtD
Dexamethasone—NR3C1—Transcription factor regulation in adipogenesis—TNF—acquired immunodeficiency syndrome	9.49e-05	0.00364	CbGpPWpGaD
Dexamethasone—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	9.49e-05	0.000566	CcSEcCtD
Dexamethasone—ANXA1—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	9.48e-05	0.00363	CbGpPWpGaD
Dexamethasone—ANXA1—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	9.48e-05	0.00363	CbGpPWpGaD
Dexamethasone—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	9.48e-05	0.000565	CcSEcCtD
Dexamethasone—ANXA1—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	9.47e-05	0.00363	CbGpPWpGaD
Dexamethasone—Fatigue—Ritonavir—acquired immunodeficiency syndrome	9.46e-05	0.000565	CcSEcCtD
Dexamethasone—PLA2G1B—Metabolism—TAT—acquired immunodeficiency syndrome	9.45e-05	0.00362	CbGpPWpGaD
Dexamethasone—Urticaria—Delavirdine—acquired immunodeficiency syndrome	9.43e-05	0.000563	CcSEcCtD
Dexamethasone—Asthenia—Indinavir—acquired immunodeficiency syndrome	9.42e-05	0.000562	CcSEcCtD
Dexamethasone—Hypotension—Lamivudine—acquired immunodeficiency syndrome	9.42e-05	0.000562	CcSEcCtD
Dexamethasone—Pain—Ritonavir—acquired immunodeficiency syndrome	9.39e-05	0.00056	CcSEcCtD
Dexamethasone—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	9.38e-05	0.00056	CcSEcCtD
Dexamethasone—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	9.38e-05	0.00056	CcSEcCtD
Dexamethasone—Dizziness—Zidovudine—acquired immunodeficiency syndrome	9.34e-05	0.000557	CcSEcCtD
Dexamethasone—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	9.3e-05	0.000555	CcSEcCtD
Dexamethasone—Pruritus—Indinavir—acquired immunodeficiency syndrome	9.29e-05	0.000554	CcSEcCtD
Dexamethasone—ANXA1—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	9.26e-05	0.00355	CbGpPWpGaD
Dexamethasone—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALB—acquired immunodeficiency syndrome	9.23e-05	0.00354	CbGpPWpGaD
Dexamethasone—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	9.19e-05	0.000548	CcSEcCtD
Dexamethasone—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	9.18e-05	0.000548	CcSEcCtD
Dexamethasone—NOS2—Spinal Cord Injury—IFNG—acquired immunodeficiency syndrome	9.13e-05	0.0035	CbGpPWpGaD
Dexamethasone—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	9.12e-05	0.000544	CcSEcCtD
Dexamethasone—Insomnia—Lamivudine—acquired immunodeficiency syndrome	9.12e-05	0.000544	CcSEcCtD
Dexamethasone—Fatigue—Saquinavir—acquired immunodeficiency syndrome	9.11e-05	0.000543	CcSEcCtD
Dexamethasone—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	9.05e-05	0.00054	CcSEcCtD
Dexamethasone—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	9.05e-05	0.00054	CcSEcCtD
Dexamethasone—Pain—Saquinavir—acquired immunodeficiency syndrome	9.04e-05	0.000539	CcSEcCtD
Dexamethasone—ABCB1—nervous system—acquired immunodeficiency syndrome	9.03e-05	0.00143	CbGeAlD
Dexamethasone—ANXA1—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	9.03e-05	0.00346	CbGpPWpGaD
Dexamethasone—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	8.99e-05	0.000536	CcSEcCtD
Dexamethasone—Vomiting—Zidovudine—acquired immunodeficiency syndrome	8.98e-05	0.000536	CcSEcCtD
Dexamethasone—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	8.98e-05	0.000536	CcSEcCtD
Dexamethasone—PTGS2—Calcium signaling in the CD4+ TCR pathway—IFNG—acquired immunodeficiency syndrome	8.91e-05	0.00341	CbGpPWpGaD
Dexamethasone—Rash—Zidovudine—acquired immunodeficiency syndrome	8.9e-05	0.000531	CcSEcCtD
Dexamethasone—Asthenia—Efavirenz—acquired immunodeficiency syndrome	8.9e-05	0.000531	CcSEcCtD
Dexamethasone—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	8.9e-05	0.000531	CcSEcCtD
Dexamethasone—CYP1B1—Aryl Hydrocarbon Receptor Pathway—IFNG—acquired immunodeficiency syndrome	8.88e-05	0.0034	CbGpPWpGaD
Dexamethasone—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	8.87e-05	0.000529	CcSEcCtD
Dexamethasone—Headache—Zidovudine—acquired immunodeficiency syndrome	8.85e-05	0.000528	CcSEcCtD
Dexamethasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—IL10—acquired immunodeficiency syndrome	8.79e-05	0.00337	CbGpPWpGaD
Dexamethasone—Pruritus—Efavirenz—acquired immunodeficiency syndrome	8.78e-05	0.000524	CcSEcCtD
Dexamethasone—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	8.76e-05	0.000523	CcSEcCtD
Dexamethasone—ABCB11—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	8.73e-05	0.00334	CbGpPWpGaD
Dexamethasone—Urticaria—Ritonavir—acquired immunodeficiency syndrome	8.72e-05	0.00052	CcSEcCtD
Dexamethasone—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	8.71e-05	0.000519	CcSEcCtD
Dexamethasone—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	8.7e-05	0.000519	CcSEcCtD
Dexamethasone—ABCB1—central nervous system—acquired immunodeficiency syndrome	8.7e-05	0.00137	CbGeAlD
Dexamethasone—Fatigue—Lamivudine—acquired immunodeficiency syndrome	8.69e-05	0.000518	CcSEcCtD
Dexamethasone—Dizziness—Indinavir—acquired immunodeficiency syndrome	8.68e-05	0.000518	CcSEcCtD
Dexamethasone—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	8.68e-05	0.000518	CcSEcCtD
Dexamethasone—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	8.68e-05	0.000518	CcSEcCtD
Dexamethasone—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	8.64e-05	0.000515	CcSEcCtD
Dexamethasone—Pain—Lamivudine—acquired immunodeficiency syndrome	8.62e-05	0.000514	CcSEcCtD
Dexamethasone—NR3C1—Glucocorticoid receptor regulatory network—CSF2—acquired immunodeficiency syndrome	8.61e-05	0.0033	CbGpPWpGaD
Dexamethasone—ANXA1—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	8.53e-05	0.00327	CbGpPWpGaD
Dexamethasone—Asthenia—Delavirdine—acquired immunodeficiency syndrome	8.52e-05	0.000508	CcSEcCtD
Dexamethasone—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	8.49e-05	0.000506	CcSEcCtD
Dexamethasone—NR3C1—Glucocorticoid receptor regulatory network—IL4—acquired immunodeficiency syndrome	8.47e-05	0.00324	CbGpPWpGaD
Dexamethasone—Pruritus—Delavirdine—acquired immunodeficiency syndrome	8.4e-05	0.000501	CcSEcCtD
Dexamethasone—Urticaria—Saquinavir—acquired immunodeficiency syndrome	8.39e-05	0.000501	CcSEcCtD
Dexamethasone—Nausea—Zidovudine—acquired immunodeficiency syndrome	8.39e-05	0.0005	CcSEcCtD
Dexamethasone—ANXA1—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	8.37e-05	0.00321	CbGpPWpGaD
Dexamethasone—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	8.35e-05	0.000498	CcSEcCtD
Dexamethasone—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	8.35e-05	0.000498	CcSEcCtD
Dexamethasone—Vomiting—Indinavir—acquired immunodeficiency syndrome	8.35e-05	0.000498	CcSEcCtD
Dexamethasone—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	8.31e-05	0.000496	CcSEcCtD
Dexamethasone—NOS2—ATF-2 transcription factor network—IL6—acquired immunodeficiency syndrome	8.3e-05	0.00318	CbGpPWpGaD
Dexamethasone—Rash—Indinavir—acquired immunodeficiency syndrome	8.28e-05	0.000494	CcSEcCtD
Dexamethasone—Dermatitis—Indinavir—acquired immunodeficiency syndrome	8.27e-05	0.000494	CcSEcCtD
Dexamethasone—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	8.24e-05	0.000492	CcSEcCtD
Dexamethasone—Headache—Indinavir—acquired immunodeficiency syndrome	8.23e-05	0.000491	CcSEcCtD
Dexamethasone—Dizziness—Efavirenz—acquired immunodeficiency syndrome	8.2e-05	0.000489	CcSEcCtD
Dexamethasone—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	8.12e-05	0.000485	CcSEcCtD
Dexamethasone—NOS2—Spinal Cord Injury—IL2—acquired immunodeficiency syndrome	8.11e-05	0.00311	CbGpPWpGaD
Dexamethasone—PTGS2—Overview of nanoparticle effects—TNF—acquired immunodeficiency syndrome	8.09e-05	0.0031	CbGpPWpGaD
Dexamethasone—PLA2G1B—Metabolism—AGPS—acquired immunodeficiency syndrome	8.03e-05	0.00308	CbGpPWpGaD
Dexamethasone—Urticaria—Lamivudine—acquired immunodeficiency syndrome	8.01e-05	0.000478	CcSEcCtD
Dexamethasone—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	7.97e-05	0.000475	CcSEcCtD
Dexamethasone—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	7.97e-05	0.000475	CcSEcCtD
Dexamethasone—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2—acquired immunodeficiency syndrome	7.92e-05	0.00303	CbGpPWpGaD
Dexamethasone—CYP1B1—Aryl Hydrocarbon Receptor Pathway—IL2—acquired immunodeficiency syndrome	7.89e-05	0.00302	CbGpPWpGaD
Dexamethasone—Vomiting—Efavirenz—acquired immunodeficiency syndrome	7.89e-05	0.000471	CcSEcCtD
Dexamethasone—Asthenia—Ritonavir—acquired immunodeficiency syndrome	7.88e-05	0.00047	CcSEcCtD
Dexamethasone—Dizziness—Delavirdine—acquired immunodeficiency syndrome	7.85e-05	0.000468	CcSEcCtD
Dexamethasone—ANXA1—Spinal Cord Injury—TNF—acquired immunodeficiency syndrome	7.83e-05	0.003	CbGpPWpGaD
Dexamethasone—Rash—Efavirenz—acquired immunodeficiency syndrome	7.82e-05	0.000467	CcSEcCtD
Dexamethasone—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	7.82e-05	0.000466	CcSEcCtD
Dexamethasone—Nausea—Indinavir—acquired immunodeficiency syndrome	7.8e-05	0.000465	CcSEcCtD
Dexamethasone—Headache—Efavirenz—acquired immunodeficiency syndrome	7.77e-05	0.000464	CcSEcCtD
Dexamethasone—Pruritus—Ritonavir—acquired immunodeficiency syndrome	7.77e-05	0.000463	CcSEcCtD
Dexamethasone—NR3C1—Transcription factor regulation in adipogenesis—IL6—acquired immunodeficiency syndrome	7.66e-05	0.00293	CbGpPWpGaD
Dexamethasone—Asthenia—Saquinavir—acquired immunodeficiency syndrome	7.58e-05	0.000452	CcSEcCtD
Dexamethasone—NR3C2—Gene Expression—CCNT1—acquired immunodeficiency syndrome	7.55e-05	0.00289	CbGpPWpGaD
Dexamethasone—Vomiting—Delavirdine—acquired immunodeficiency syndrome	7.55e-05	0.00045	CcSEcCtD
Dexamethasone—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	7.51e-05	0.000448	CcSEcCtD
Dexamethasone—Rash—Delavirdine—acquired immunodeficiency syndrome	7.49e-05	0.000447	CcSEcCtD
Dexamethasone—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	7.48e-05	0.000446	CcSEcCtD
Dexamethasone—Pruritus—Saquinavir—acquired immunodeficiency syndrome	7.48e-05	0.000446	CcSEcCtD
Dexamethasone—CYP3A43—Metabolism—TAT—acquired immunodeficiency syndrome	7.44e-05	0.00285	CbGpPWpGaD
Dexamethasone—Headache—Delavirdine—acquired immunodeficiency syndrome	7.44e-05	0.000444	CcSEcCtD
Dexamethasone—Nausea—Efavirenz—acquired immunodeficiency syndrome	7.37e-05	0.00044	CcSEcCtD
Dexamethasone—ABCB1—HIF-1-alpha transcription factor network—CXCR4—acquired immunodeficiency syndrome	7.34e-05	0.00281	CbGpPWpGaD
Dexamethasone—ABCB1—HIF-1-alpha transcription factor network—CXCL12—acquired immunodeficiency syndrome	7.34e-05	0.00281	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	7.29e-05	0.00279	CbGpPWpGaD
Dexamethasone—Dizziness—Ritonavir—acquired immunodeficiency syndrome	7.26e-05	0.000433	CcSEcCtD
Dexamethasone—Asthenia—Lamivudine—acquired immunodeficiency syndrome	7.23e-05	0.000431	CcSEcCtD
Dexamethasone—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	7.23e-05	0.000431	CcSEcCtD
Dexamethasone—ANXA1—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	7.21e-05	0.00276	CbGpPWpGaD
Dexamethasone—Pruritus—Lamivudine—acquired immunodeficiency syndrome	7.13e-05	0.000425	CcSEcCtD
Dexamethasone—CYP11A1—Corticotropin-releasing hormone—IL2—acquired immunodeficiency syndrome	7.1e-05	0.00272	CbGpPWpGaD
Dexamethasone—Nausea—Delavirdine—acquired immunodeficiency syndrome	7.05e-05	0.000421	CcSEcCtD
Dexamethasone—Dizziness—Saquinavir—acquired immunodeficiency syndrome	6.99e-05	0.000417	CcSEcCtD
Dexamethasone—Vomiting—Ritonavir—acquired immunodeficiency syndrome	6.98e-05	0.000416	CcSEcCtD
Dexamethasone—NOS2—Disease—APOBEC3G—acquired immunodeficiency syndrome	6.93e-05	0.00265	CbGpPWpGaD
Dexamethasone—Rash—Ritonavir—acquired immunodeficiency syndrome	6.92e-05	0.000413	CcSEcCtD
Dexamethasone—PTGS2—Spinal Cord Injury—CCR2—acquired immunodeficiency syndrome	6.92e-05	0.00265	CbGpPWpGaD
Dexamethasone—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	6.92e-05	0.000413	CcSEcCtD
Dexamethasone—ABCB1—brain—acquired immunodeficiency syndrome	6.9e-05	0.00109	CbGeAlD
Dexamethasone—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	6.9e-05	0.000411	CcSEcCtD
Dexamethasone—Headache—Ritonavir—acquired immunodeficiency syndrome	6.88e-05	0.00041	CcSEcCtD
Dexamethasone—Vomiting—Saquinavir—acquired immunodeficiency syndrome	6.72e-05	0.000401	CcSEcCtD
Dexamethasone—ABCB1—lymph node—acquired immunodeficiency syndrome	6.67e-05	0.00105	CbGeAlD
Dexamethasone—Dizziness—Lamivudine—acquired immunodeficiency syndrome	6.67e-05	0.000398	CcSEcCtD
Dexamethasone—Rash—Saquinavir—acquired immunodeficiency syndrome	6.66e-05	0.000397	CcSEcCtD
Dexamethasone—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	6.66e-05	0.000397	CcSEcCtD
Dexamethasone—Headache—Saquinavir—acquired immunodeficiency syndrome	6.62e-05	0.000395	CcSEcCtD
Dexamethasone—CYP19A1—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	6.59e-05	0.00252	CbGpPWpGaD
Dexamethasone—PTGS2—Overview of nanoparticle effects—IL6—acquired immunodeficiency syndrome	6.53e-05	0.0025	CbGpPWpGaD
Dexamethasone—Nausea—Ritonavir—acquired immunodeficiency syndrome	6.52e-05	0.000389	CcSEcCtD
Dexamethasone—ANXA1—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	6.5e-05	0.00249	CbGpPWpGaD
Dexamethasone—Vomiting—Lamivudine—acquired immunodeficiency syndrome	6.41e-05	0.000382	CcSEcCtD
Dexamethasone—ABCB1—Allograft Rejection—CXCL12—acquired immunodeficiency syndrome	6.36e-05	0.00244	CbGpPWpGaD
Dexamethasone—Rash—Lamivudine—acquired immunodeficiency syndrome	6.36e-05	0.000379	CcSEcCtD
Dexamethasone—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	6.35e-05	0.000379	CcSEcCtD
Dexamethasone—CYP1B1—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	6.34e-05	0.00243	CbGpPWpGaD
Dexamethasone—CYP3A43—Metabolism—AGPS—acquired immunodeficiency syndrome	6.32e-05	0.00242	CbGpPWpGaD
Dexamethasone—ANXA1—Spinal Cord Injury—IL6—acquired immunodeficiency syndrome	6.32e-05	0.00242	CbGpPWpGaD
Dexamethasone—Headache—Lamivudine—acquired immunodeficiency syndrome	6.31e-05	0.000377	CcSEcCtD
Dexamethasone—Nausea—Saquinavir—acquired immunodeficiency syndrome	6.28e-05	0.000374	CcSEcCtD
Dexamethasone—NOS2—Hemostasis—IFNA1—acquired immunodeficiency syndrome	6.12e-05	0.00235	CbGpPWpGaD
Dexamethasone—Nausea—Lamivudine—acquired immunodeficiency syndrome	5.99e-05	0.000357	CcSEcCtD
Dexamethasone—NOS2—Spinal Cord Injury—TNF—acquired immunodeficiency syndrome	5.91e-05	0.00226	CbGpPWpGaD
Dexamethasone—NOS2—Disease—CCNT1—acquired immunodeficiency syndrome	5.89e-05	0.00226	CbGpPWpGaD
Dexamethasone—NR3C1—AP-1 transcription factor network—IFNG—acquired immunodeficiency syndrome	5.81e-05	0.00223	CbGpPWpGaD
Dexamethasone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—acquired immunodeficiency syndrome	5.76e-05	0.00221	CbGpPWpGaD
Dexamethasone—CYP1B1—Aryl Hydrocarbon Receptor Pathway—TNF—acquired immunodeficiency syndrome	5.75e-05	0.0022	CbGpPWpGaD
Dexamethasone—CYP1B1—Aryl Hydrocarbon Receptor—TNF—acquired immunodeficiency syndrome	5.75e-05	0.0022	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	5.72e-05	0.00219	CbGpPWpGaD
Dexamethasone—ANXA1—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	5.7e-05	0.00218	CbGpPWpGaD
Dexamethasone—CYP17A1—Metabolism—TAT—acquired immunodeficiency syndrome	5.69e-05	0.00218	CbGpPWpGaD
Dexamethasone—NR3C1—Generic Transcription Pathway—CCNT1—acquired immunodeficiency syndrome	5.52e-05	0.00212	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	5.47e-05	0.0021	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	5.47e-05	0.0021	CbGpPWpGaD
Dexamethasone—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IFNG—acquired immunodeficiency syndrome	5.47e-05	0.00209	CbGpPWpGaD
Dexamethasone—ANXA1—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	5.36e-05	0.00205	CbGpPWpGaD
Dexamethasone—ANXA1—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	5.36e-05	0.00205	CbGpPWpGaD
Dexamethasone—ANXA1—Integrated Pancreatic Cancer Pathway—TNF—acquired immunodeficiency syndrome	5.33e-05	0.00204	CbGpPWpGaD
Dexamethasone—CYP11A1—Metabolism—TAT—acquired immunodeficiency syndrome	5.21e-05	0.00199	CbGpPWpGaD
Dexamethasone—NR3C1—SIDS Susceptibility Pathways—IL10—acquired immunodeficiency syndrome	5.2e-05	0.00199	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	5.17e-05	0.00198	CbGpPWpGaD
Dexamethasone—NR3C1—AP-1 transcription factor network—IL2—acquired immunodeficiency syndrome	5.16e-05	0.00198	CbGpPWpGaD
Dexamethasone—CYP4A11—Metabolism—TAT—acquired immunodeficiency syndrome	5.15e-05	0.00197	CbGpPWpGaD
Dexamethasone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—acquired immunodeficiency syndrome	5.12e-05	0.00196	CbGpPWpGaD
Dexamethasone—NR3C1—Glucocorticoid receptor regulatory network—IFNG—acquired immunodeficiency syndrome	5.12e-05	0.00196	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	4.95e-05	0.00189	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	4.94e-05	0.00189	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	4.86e-05	0.00186	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	4.86e-05	0.00186	CbGpPWpGaD
Dexamethasone—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL2—acquired immunodeficiency syndrome	4.86e-05	0.00186	CbGpPWpGaD
Dexamethasone—CYP17A1—Metabolism—AGPS—acquired immunodeficiency syndrome	4.84e-05	0.00185	CbGpPWpGaD
Dexamethasone—ABCB1—Allograft Rejection—CD40LG—acquired immunodeficiency syndrome	4.82e-05	0.00185	CbGpPWpGaD
Dexamethasone—ABCB1—Allograft Rejection—IL10—acquired immunodeficiency syndrome	4.82e-05	0.00185	CbGpPWpGaD
Dexamethasone—PTGS2—Spinal Cord Injury—IL4—acquired immunodeficiency syndrome	4.8e-05	0.00184	CbGpPWpGaD
Dexamethasone—NOS2—Hemostasis—CSF2—acquired immunodeficiency syndrome	4.79e-05	0.00184	CbGpPWpGaD
Dexamethasone—NOS2—Spinal Cord Injury—IL6—acquired immunodeficiency syndrome	4.77e-05	0.00183	CbGpPWpGaD
Dexamethasone—ABCB1—Allograft Rejection—IL4—acquired immunodeficiency syndrome	4.69e-05	0.0018	CbGpPWpGaD
Dexamethasone—PGR—Gene Expression—CCNT1—acquired immunodeficiency syndrome	4.6e-05	0.00176	CbGpPWpGaD
Dexamethasone—ABCB1—Allograft Rejection—HLA-B—acquired immunodeficiency syndrome	4.58e-05	0.00176	CbGpPWpGaD
Dexamethasone—ABCB11—Metabolism—TAT—acquired immunodeficiency syndrome	4.57e-05	0.00175	CbGpPWpGaD
Dexamethasone—NR3C1—Glucocorticoid receptor regulatory network—IL2—acquired immunodeficiency syndrome	4.55e-05	0.00174	CbGpPWpGaD
Dexamethasone—CYP11A1—Metabolism—AGPS—acquired immunodeficiency syndrome	4.43e-05	0.0017	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	4.4e-05	0.00169	CbGpPWpGaD
Dexamethasone—CYP4A11—Metabolism—AGPS—acquired immunodeficiency syndrome	4.38e-05	0.00168	CbGpPWpGaD
Dexamethasone—ANXA1—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	4.07e-05	0.00156	CbGpPWpGaD
Dexamethasone—PTGS2—Selenium Micronutrient Network—ALB—acquired immunodeficiency syndrome	4.02e-05	0.00154	CbGpPWpGaD
Dexamethasone—ANXA1—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	4.01e-05	0.00154	CbGpPWpGaD
Dexamethasone—PTGS2—Aryl Hydrocarbon Receptor—TNF—acquired immunodeficiency syndrome	3.99e-05	0.00153	CbGpPWpGaD
Dexamethasone—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	3.91e-05	0.0015	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	3.91e-05	0.0015	CbGpPWpGaD
Dexamethasone—ABCB11—Metabolism—AGPS—acquired immunodeficiency syndrome	3.89e-05	0.00149	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism—TAT—acquired immunodeficiency syndrome	3.82e-05	0.00146	CbGpPWpGaD
Dexamethasone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—acquired immunodeficiency syndrome	3.73e-05	0.00143	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	3.7e-05	0.00142	CbGpPWpGaD
Dexamethasone—PLA2G1B—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	3.7e-05	0.00142	CbGpPWpGaD
Dexamethasone—PTGS2—C-MYB transcription factor network—CD4—acquired immunodeficiency syndrome	3.68e-05	0.00141	CbGpPWpGaD
Dexamethasone—ANXA1—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	3.67e-05	0.00141	CbGpPWpGaD
Dexamethasone—PTGS2—Selenium Micronutrient Network—IFNG—acquired immunodeficiency syndrome	3.67e-05	0.0014	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	3.64e-05	0.0014	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	3.58e-05	0.00137	CbGpPWpGaD
Dexamethasone—CYP1A1—Aryl Hydrocarbon Receptor—TNF—acquired immunodeficiency syndrome	3.54e-05	0.00136	CbGpPWpGaD
Dexamethasone—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—acquired immunodeficiency syndrome	3.54e-05	0.00136	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism—TAT—acquired immunodeficiency syndrome	3.45e-05	0.00132	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	3.38e-05	0.00129	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	3.33e-05	0.00128	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism—TAT—acquired immunodeficiency syndrome	3.32e-05	0.00127	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism—AGPS—acquired immunodeficiency syndrome	3.25e-05	0.00124	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	3.2e-05	0.00122	CbGpPWpGaD
Dexamethasone—NOS2—Hemostasis—ALB—acquired immunodeficiency syndrome	3.12e-05	0.0012	CbGpPWpGaD
Dexamethasone—NOS2—Circadian rythm related genes—IL6—acquired immunodeficiency syndrome	3.11e-05	0.00119	CbGpPWpGaD
Dexamethasone—NOS2—Disease—CXCR4—acquired immunodeficiency syndrome	3.09e-05	0.00119	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	3.06e-05	0.00117	CbGpPWpGaD
Dexamethasone—NR3C1—AP-1 transcription factor network—IL6—acquired immunodeficiency syndrome	3.03e-05	0.00116	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—TAT—acquired immunodeficiency syndrome	3.02e-05	0.00116	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—TAT—acquired immunodeficiency syndrome	3e-05	0.00115	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	2.99e-05	0.00115	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	2.99e-05	0.00115	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism—AGPS—acquired immunodeficiency syndrome	2.93e-05	0.00112	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	2.91e-05	0.00112	CbGpPWpGaD
Dexamethasone—PTGS2—Spinal Cord Injury—IFNG—acquired immunodeficiency syndrome	2.9e-05	0.00111	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	2.87e-05	0.0011	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	2.87e-05	0.0011	CbGpPWpGaD
Dexamethasone—ABCB1—Allograft Rejection—IFNG—acquired immunodeficiency syndrome	2.83e-05	0.00109	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism—AGPS—acquired immunodeficiency syndrome	2.82e-05	0.00108	CbGpPWpGaD
Dexamethasone—PGR—Signaling by ERBB4—IL6—acquired immunodeficiency syndrome	2.82e-05	0.00108	CbGpPWpGaD
Dexamethasone—SLCO1A2—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	2.8e-05	0.00107	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—TAT—acquired immunodeficiency syndrome	2.75e-05	0.00105	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	2.7e-05	0.00104	CbGpPWpGaD
Dexamethasone—NR3C1—Glucocorticoid receptor regulatory network—IL6—acquired immunodeficiency syndrome	2.67e-05	0.00102	CbGpPWpGaD
Dexamethasone—NR3C1—Gene Expression—CCNT1—acquired immunodeficiency syndrome	2.66e-05	0.00102	CbGpPWpGaD
Dexamethasone—PTGS2—Spinal Cord Injury—IL2—acquired immunodeficiency syndrome	2.58e-05	0.000987	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—AGPS—acquired immunodeficiency syndrome	2.57e-05	0.000984	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—AGPS—acquired immunodeficiency syndrome	2.55e-05	0.000976	CbGpPWpGaD
Dexamethasone—NOS2—Hemostasis—IL2—acquired immunodeficiency syndrome	2.53e-05	0.00097	CbGpPWpGaD
Dexamethasone—ABCB1—Allograft Rejection—IL2—acquired immunodeficiency syndrome	2.52e-05	0.000964	CbGpPWpGaD
Dexamethasone—PTGS2—Selenium Micronutrient Network—TNF—acquired immunodeficiency syndrome	2.37e-05	0.000909	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—AGPS—acquired immunodeficiency syndrome	2.33e-05	0.000894	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—TAT—acquired immunodeficiency syndrome	2.3e-05	0.000883	CbGpPWpGaD
Dexamethasone—NR3C1—Adipogenesis—TNF—acquired immunodeficiency syndrome	2.29e-05	0.000878	CbGpPWpGaD
Dexamethasone—CYP17A1—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	2.23e-05	0.000854	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—TAT—acquired immunodeficiency syndrome	2.22e-05	0.000849	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—APOBEC3G—acquired immunodeficiency syndrome	2.2e-05	0.000843	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	2.19e-05	0.000837	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—TAT—acquired immunodeficiency syndrome	2.17e-05	0.000831	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—TAT—acquired immunodeficiency syndrome	2.17e-05	0.000829	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	2.15e-05	0.000825	CbGpPWpGaD
Dexamethasone—NOS2—Disease—CCR5—acquired immunodeficiency syndrome	2.12e-05	0.000813	CbGpPWpGaD
Dexamethasone—ANXA1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	2.12e-05	0.000812	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—TAT—acquired immunodeficiency syndrome	2.05e-05	0.000784	CbGpPWpGaD
Dexamethasone—CYP11A1—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	2.04e-05	0.000781	CbGpPWpGaD
Dexamethasone—CYP4A11—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	2.02e-05	0.000773	CbGpPWpGaD
Dexamethasone—NR3C1—SIDS Susceptibility Pathways—TNF—acquired immunodeficiency syndrome	1.98e-05	0.000759	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.97e-05	0.000754	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—AGPS—acquired immunodeficiency syndrome	1.96e-05	0.000751	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.93e-05	0.000738	CbGpPWpGaD
Dexamethasone—PTGS2—Selenium Micronutrient Network—IL6—acquired immunodeficiency syndrome	1.91e-05	0.000733	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—AGPS—acquired immunodeficiency syndrome	1.88e-05	0.000722	CbGpPWpGaD
Dexamethasone—PTGS2—Spinal Cord Injury—TNF—acquired immunodeficiency syndrome	1.88e-05	0.000719	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—TAT—acquired immunodeficiency syndrome	1.88e-05	0.000718	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—CCNT1—acquired immunodeficiency syndrome	1.87e-05	0.000717	CbGpPWpGaD
Dexamethasone—NR3C1—Adipogenesis—IL6—acquired immunodeficiency syndrome	1.85e-05	0.000708	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.85e-05	0.000708	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—AGPS—acquired immunodeficiency syndrome	1.84e-05	0.000707	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—AGPS—acquired immunodeficiency syndrome	1.84e-05	0.000705	CbGpPWpGaD
Dexamethasone—ABCB1—Allograft Rejection—TNF—acquired immunodeficiency syndrome	1.83e-05	0.000702	CbGpPWpGaD
Dexamethasone—ABCB11—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	1.79e-05	0.000686	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—AGPS—acquired immunodeficiency syndrome	1.74e-05	0.000666	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—TAT—acquired immunodeficiency syndrome	1.67e-05	0.000641	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.67e-05	0.00064	CbGpPWpGaD
Dexamethasone—PLA2G1B—Metabolism—ALB—acquired immunodeficiency syndrome	1.65e-05	0.000631	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—TAT—acquired immunodeficiency syndrome	1.63e-05	0.000626	CbGpPWpGaD
Dexamethasone—NR3C1—SIDS Susceptibility Pathways—IL6—acquired immunodeficiency syndrome	1.6e-05	0.000612	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—AGPS—acquired immunodeficiency syndrome	1.59e-05	0.000611	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.57e-05	0.000602	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.57e-05	0.000602	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—TAT—acquired immunodeficiency syndrome	1.54e-05	0.00059	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—TAT—acquired immunodeficiency syndrome	1.53e-05	0.000585	CbGpPWpGaD
Dexamethasone—PTGS2—Spinal Cord Injury—IL6—acquired immunodeficiency syndrome	1.51e-05	0.00058	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	1.49e-05	0.000572	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—AGPS—acquired immunodeficiency syndrome	1.42e-05	0.000545	CbGpPWpGaD
Dexamethasone—SLCO1A2—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	1.42e-05	0.000544	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—AGPS—acquired immunodeficiency syndrome	1.39e-05	0.000532	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	1.35e-05	0.000517	CbGpPWpGaD
Dexamethasone—NOS2—Disease—CD4—acquired immunodeficiency syndrome	1.33e-05	0.00051	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—AGPS—acquired immunodeficiency syndrome	1.31e-05	0.000501	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	1.3e-05	0.000498	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—AGPS—acquired immunodeficiency syndrome	1.3e-05	0.000497	CbGpPWpGaD
Dexamethasone—CYP3A43—Metabolism—ALB—acquired immunodeficiency syndrome	1.3e-05	0.000497	CbGpPWpGaD
Dexamethasone—ABCC2—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	1.29e-05	0.000496	CbGpPWpGaD
Dexamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—acquired immunodeficiency syndrome	1.28e-05	0.000489	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.2e-05	0.000458	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.18e-05	0.000451	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.14e-05	0.000436	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	1.13e-05	0.000434	CbGpPWpGaD
Dexamethasone—ABCG2—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	1.13e-05	0.000431	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.08e-05	0.000412	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—TAT—acquired immunodeficiency syndrome	1.01e-05	0.000386	CbGpPWpGaD
Dexamethasone—CYP17A1—Metabolism—ALB—acquired immunodeficiency syndrome	9.93e-06	0.00038	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—CXCR4—acquired immunodeficiency syndrome	9.83e-06	0.000376	CbGpPWpGaD
Dexamethasone—CYP11A1—Metabolism—ALB—acquired immunodeficiency syndrome	9.08e-06	0.000348	CbGpPWpGaD
Dexamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—acquired immunodeficiency syndrome	9.05e-06	0.000347	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	9.03e-06	0.000346	CbGpPWpGaD
Dexamethasone—CYP4A11—Metabolism—ALB—acquired immunodeficiency syndrome	8.99e-06	0.000344	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—AGPS—acquired immunodeficiency syndrome	8.56e-06	0.000328	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	8.01e-06	0.000307	CbGpPWpGaD
Dexamethasone—ABCB11—Metabolism—ALB—acquired immunodeficiency syndrome	7.97e-06	0.000305	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	7.34e-06	0.000281	CbGpPWpGaD
Dexamethasone—NOS2—Disease—IL6—acquired immunodeficiency syndrome	7.2e-06	0.000276	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—CCR5—acquired immunodeficiency syndrome	6.74e-06	0.000258	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	6.69e-06	0.000256	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism—ALB—acquired immunodeficiency syndrome	6.66e-06	0.000255	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	6.55e-06	0.000251	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—IL2—acquired immunodeficiency syndrome	6.22e-06	0.000238	CbGpPWpGaD
Dexamethasone—ABCB1—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	6.08e-06	0.000233	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism—ALB—acquired immunodeficiency syndrome	6.02e-06	0.00023	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	5.98e-06	0.000229	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism—ALB—acquired immunodeficiency syndrome	5.79e-06	0.000222	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—ALB—acquired immunodeficiency syndrome	5.27e-06	0.000202	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—ALB—acquired immunodeficiency syndrome	5.22e-06	0.0002	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—ALB—acquired immunodeficiency syndrome	4.79e-06	0.000183	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—CD4—acquired immunodeficiency syndrome	4.23e-06	0.000162	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—ALB—acquired immunodeficiency syndrome	4.02e-06	0.000154	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—ALB—acquired immunodeficiency syndrome	3.86e-06	0.000148	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—ALB—acquired immunodeficiency syndrome	3.78e-06	0.000145	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—ALB—acquired immunodeficiency syndrome	3.78e-06	0.000145	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—IL6—acquired immunodeficiency syndrome	3.66e-06	0.00014	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—ALB—acquired immunodeficiency syndrome	3.57e-06	0.000137	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—ALB—acquired immunodeficiency syndrome	3.27e-06	0.000125	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—ALB—acquired immunodeficiency syndrome	2.92e-06	0.000112	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—ALB—acquired immunodeficiency syndrome	2.85e-06	0.000109	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—ALB—acquired immunodeficiency syndrome	2.68e-06	0.000103	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—ALB—acquired immunodeficiency syndrome	2.66e-06	0.000102	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—IL6—acquired immunodeficiency syndrome	2.29e-06	8.76e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—ALB—acquired immunodeficiency syndrome	1.76e-06	6.72e-05	CbGpPWpGaD
